Connection

Search Results to Rangaraj Selvarangan

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Selvarangan, Rangaraj

One or more keywords matched the following properties of Selvarangan, Rangaraj

Property

Value

research overview

Dr. Selvarangan is the Director of the Clinical Microbiology and Molecular Infectious Diseases Laboratory in Children’s Mercy Hospital accredited by College of American Pathologists. He has more than fifteen years of experience with directorship of high complexity clinical laboratory testing and research in the area of laboratory test evaluation and selection for implementation in routine clinical care. His research area encompasses advanced diagnostics for infectious diseases, epidemiology of infections in children, vaccine related studies, biomarker discovery and host response to infections and interventions to improve patient care and outcomes. His clinical research experience also includes federal funding and more than 100 clinical trials supported by In vitro diagnostic industry. His research team specializes in large volume prospective enrollment of children in clinical trials for infectious diseases in outpatient and inpatient settings. As the founding Principal Investigator of Kansas City-New Vaccine Surveillance Network (KC-NVSN) program since 2009, sponsored by Centers for Disease Control and Prevention, he has direct working knowledge on establishment and collaboration of multisite national networks.

One or more keywords matched the following items that are connected to Selvarangan, Rangaraj

Item Type	Name
Concept	Population Surveillance
Concept	Public Health Surveillance
Academic Article	Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool.
Academic Article	Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.
Academic Article	Evidence for Household Transmission of Rotavirus in the United States, 2011-2016.
Academic Article	Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018.
Academic Article	Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
Grant	Kansas City - New Vaccine Surveillance Network (KC-NVSN)
Academic Article	Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020.
Academic Article	Rotavirus Genotype Trends and Gastrointestinal Pathogen Detection in the United States, 2014-2016: Results From the New Vaccine Surveillance Network.
Grant	Enhanced Surveillance for New Vaccine Preventable Diseases
Academic Article	Real-time gastrointestinal infection surveillance through a cloud-based network of clinical laboratories.
Academic Article	Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study.
Academic Article	Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-November 2018-2020.
Academic Article	Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children <18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018.
Academic Article	Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020.
Academic Article	Rotavirus Strain Trends in United States, 2009-2016: Results from the National Rotavirus Strain Surveillance System (NRSSS).
Academic Article	Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.
Academic Article	SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023.
Academic Article	Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016-2020.

Search Criteria

Surveillance